CLINICAL_TRIALS
trial_result
· 2012-06-27
Clinical Trial Update: Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder [Phase 3]
Summary
Phase 3 relapse-prevention trial of desvenlafaxine sustained release in outpatients with major depressive disorder has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2012-06-27